Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) EPS (Weighted Average and Diluted): 2021-2023

Historic EPS (Weighted Average and Diluted) for Aytu Biopharma (AYTU) over the last 3 years, with Jun 2023 value amounting to -$5.11.

  • Aytu Biopharma's EPS (Weighted Average and Diluted) rose 60.00% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 83.25%. This contributed to the annual value of -$5.11 for FY2023, which is 93.10% up from last year.
  • According to the latest figures from FY2023, Aytu Biopharma's EPS (Weighted Average and Diluted) is -$5.11, which was up 93.10% from -$74.01 recorded in FY2022.
  • Aytu Biopharma's 5-year EPS (Weighted Average and Diluted) high stood at -$3.48 for FY2021, and its period low was -$74.01 during FY2022.
  • Over the past 3 years, Aytu Biopharma's median EPS (Weighted Average and Diluted) value was -$5.11 (recorded in 2023), while the average stood at -$27.53.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 2,026.72% in 2022, then skyrocketed by 93.10% in 2023.
  • Aytu Biopharma's EPS (Weighted Average and Diluted) (Yearly) stood at -$3.48 in 2021, then tumbled by 2,026.72% to -$74.01 in 2022, then skyrocketed by 93.10% to -$5.11 in 2023.